Lineage Cell Therapeutics, Inc. (LCTX)
1.355
-0.02
(-1.09%)
USD |
NYAM |
May 11, 11:45
Lineage Cell Therapeutics Market Cap : 337.51M for May 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Prime Medicine, Inc. | 620.42M |
| ACADIA Pharmaceuticals, Inc. | 3.803B |
| Agenus, Inc. | 127.87M |
| Alnylam Pharmaceuticals, Inc. | 38.95B |
| Amgen, Inc. | 178.42B |
Market Cap Related Metrics
| PS Ratio | 21.56 |
| PEG Ratio | -0.0261 |
| Price to Book Value | 7.576 |
| Price | 1.355 |
| Earnings Yield | -20.54% |
| PEGY Ratio | -0.0261 |